GGrantIndex
← Search

PHASE II STUDY OF AUTOLOGOUS CD4 ZETA GENE MODIFIED T CELLS IN HIV

$207,266M01FY2000RRNIH

University Of California Los Angeles, Los Angeles CA

Investigators

Linked publications, trials & patents

View original record on NIH RePORTER →
PHASE II STUDY OF AUTOLOGOUS CD4 ZETA GENE MODIFIED T CELLS IN HIV · GrantIndex